JPMORGAN CHASE & CO - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 34 filers reported holding AIM IMMUNOTECH INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q3 2023$27
+1250.0%
60
+1900.0%
0.00%
Q2 2023$230.0%0.00%
Q1 2023$030.0%0.00%
Q4 2022$030.0%0.00%
Q3 2022$030.0%0.00%
Q2 2022$030.0%0.00%
Q1 2022$0
-100.0%
3
-99.9%
0.00%
Q4 2021$2,000
-60.0%
2,620
+0.8%
0.00%
Q3 2021$5,0000.0%2,598
+8.3%
0.00%
Q2 2021$5,0002,399
+119850.0%
0.00%
Q1 2021$0
-100.0%
2
-99.9%
0.00%
Q4 2020$5,000
-86.5%
3,052
-82.4%
0.00%
Q3 2020$37,00017,369
+868350.0%
0.00%
Q2 2020$020.0%0.00%
Q1 2020$020.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q2 2023
NameSharesValueWeighting ↓
ForthRight Wealth Management, LLC 20,000$13,4000.01%
SeaCrest Wealth Management, LLC 37,063$24,8320.00%
D.B. Root & Company, LLC 12,050$8,0740.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 108,900$72,9630.00%
Traynor Capital Management, Inc. 11,777$7,8910.00%
Community Bank, N.A. 13,226$8,8610.00%
Verition Fund Management LLC 140,000$93,8000.00%
DRW Securities, LLC 37,000$250.00%
SNS Financial Group, LLC 10,000$6,7000.00%
HUNTINGTON NATIONAL BANK 57$380.00%
View complete list of AIM IMMUNOTECH INC shareholders